Alpha 2.0
Login Register
» Articles » PMID: 30144151

Prognostic Value of Prior Consolidation in Acute Myeloid Leukemia Patients Undergoing Hematopoietic Cell Transplantation in Minimal Residual Disease-negative First Complete Remission

Overview
Journal Am J Hematol
Specialty Hematology
Date 2018 Aug 26
PMID 30144151
Citations 2
Authors
Joan How
Kiran R Vij
Maryam Ebadi
Todd E DeFor
Rizwan Romee
Michelle M Dolan
Celalettin Ustun
Daniel J Weisdorf
Michael A Linden
Armin Rashidi
Affiliations
Soon will be listed here.
Citing Articles

Intensive post-remission therapy does not decrease relapse after allotransplants for acute myeloid leukaemia in 1st remission and should not be given.

Rodriguez-Arboli E, Phillips G, Pardee T, Lazarus H, Gale R Leukemia. 2025; .

PMID: 40074851 DOI: 10.1038/s41375-025-02560-3.

More than two courses of pre-transplant consolidation therapy benefits patients with acute myeloid leukemia in the first complete remission who underwent human leukocyte antigen-matched sibling allografts: a multicenter study.

Liu J, Wu D, Liu Q, Chang Y, Xu Y, Huang F Chin Med J (Engl). 2023; 136(15):1855-1863.

PMID: 36730715 PMC: 10406017. DOI: 10.1097/CM9.0000000000002347.

[Effect of consolidation before allogeneic hematopoietic stem cell transplantation for non-favorable acute myeloid leukemia patients with first complete remisson and negative minimal residual disease].

Zhang Y, Zhang Y, Ni X, Gao L, Qiu H, Zhang Y Zhonghua Xue Ye Xue Za Zhi. 2020; 41(1):16-22.

PMID: 32023749 PMC: 7357906. DOI: 10.3760/cma.j.issn.0253-2727.2020.01.004.

References
1.
Keeney M, Halley J, Rhoads D, Ansari M, Kussick S, Karlon W . Marked Variability in Reported Minimal Residual Disease Lower Level of Detection of 4 Hematolymphoid Neoplasms: A Survey of Participants in the College of American Pathologists Flow Cytometry Proficiency Testing Program. Arch Pathol Lab Med. 2015; 139(10):1276-80. DOI: 10.5858/arpa.2014-0543-CP. View
2.
Oran B, Jorgensen J, Marin D, Wang S, Ahmed S, Alousi A . Pre-transplantation minimal residual disease with cytogenetic and molecular diagnostic features improves risk stratification in acute myeloid leukemia. Haematologica. 2016; 102(1):110-117. PMC: 5210241. DOI: 10.3324/haematol.2016.144253. View
3.
Rashidi A, Linden M, DeFor T, Warlick E, Bejanyan N, Yohe S . History of consolidation is prognostic in acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplantation in minimal residual disease-negative first complete remission. Am J Hematol. 2017; 92(10):1032-1036. PMC: 5734672. DOI: 10.1002/ajh.24834. View
4.
Ustun C, Courville E, DeFor T, Dolan M, Randall N, Yohe S . Myeloablative, but not Reduced-Intensity, Conditioning Overcomes the Negative Effect of Flow-Cytometric Evidence of Leukemia in Acute Myeloid Leukemia. Biol Blood Marrow Transplant. 2015; 22(4):669-675. PMC: 4805453. DOI: 10.1016/j.bbmt.2015.10.024. View
5.
Ustun C, Wiseman A, DeFor T, Yohe S, Linden M, Oran B . Achieving stringent CR is essential before reduced-intensity conditioning allogeneic hematopoietic cell transplantation in AML. Bone Marrow Transplant. 2013; 48(11):1415-20. DOI: 10.1038/bmt.2013.124. View